Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Gene Security Network (GSN), a developer of diagnostic assays, has unveiled a new non-invasive prenatal test.
Subscribe to our email newsletter
The prenatal test is developed utilizing the company’s bioinformatics technology – Parental Support which unites single-nucleotide polymorphism (SNP) technology with bioinformatics algorithms to produce genetic information from small amounts of free-floating fetal DNA found in the mother’s blood.
GSN CEO Matthew Rabinowitz said the application of advanced statistics to non-invasive prenatal testing enables them to deliver information to expecting parents safely and early in the pregnancy.
"We are initiating a large, prospective clinical trial, funded by the National Institutes of Health (NIH), with the maternal fetal medicine centers in the US to evualate the efficacy."